Obstetrics & Gynecology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA ALERT
chemo
FDA ALERT
FDA Approves Pembrolizumab With Chemotherapy to Treat Primary Advance or Recurrent Endometrial Carcinoma in Patients
09/13/2024
Jessica Ganga
In June, following a placebo-controlled trial, the FDA approved pembrolizumab with chemotherapy to treat patients with primary advanced or recurrent endometrial carcinoma.
09/13/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves First Dissolvable Birth Control Pill
07/31/2024
Anthony Calabro, MA
The first orally disintegrating birth control tablet was designed for individuals who have trouble swallowing their medication.
07/31/2024
FDA Alert
Fda alert
FDA Alert
FDA Approves First Oral Medication for Treatment of Postpartum Depression
10/04/2023
Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
FDA Alert
fda
FDA Alert
FDA Approves First RSV Vaccine For Pregnant Individuals
08/24/2023
Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
FDA Alert
pills
FDA Alert
FDA Approves First Over-The-Counter, Nonprescription Daily Oral Contraceptive
07/21/2023
Jessica Ganga
The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.
07/21/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
FDA
FDA
FDA Approves New Option for Early Stage Breast Cancer
07/18/2017
The US Food and Drug Administration recently approved a new treatment option for patients with early stage HER2-overexpressed/amplified breast cancer. For recommended dosage and common adverse events, read...
07/18/2017
FDA
FDA
FDA Expands Indication for Metastatic Breast Cancer Treatment
04/03/2017
The FDA converted Ibrance to regular FDA approval and approved a supplemental New Drug Application for the drug, broadening its range of antihormonal therapy.
04/03/2017
Screening
Screening
FDA Warns of Ultrasound Gel Contamination
04/19/2012
A large batch of ultrasound transmission gel from Pharmaceutical Innovations Inc. in Newark, NJ has been seized in response to an FDA warning that the gel contained dangerous bacteria.
04/19/2012